142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

313011
Health pathway across all levels after the Gulf War

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 1:18 PM - 1:30 PM

Charles W. Cange, PhD, MSc , Center for Public Health and Human Rights, Johns Hopkins University, Baltimore, MD
Background

In the Kuwait context, there were a series of chemical and psychological Gulf War-era exposures that left permanent damage from January 1991 until December 1991.  ‪Extreme stress from a critical event speeds up the usual disease latency period, and may be part of a synergistic effect that leads to higher breast cancer rates over a shorter period of time.

Model Description

I am interested in the impact of armed conflict on health outcomes over the life-course in Kuwait, and particularly the pathways through which armed conflict may lead to breast cancer in health on a population level.    We used OLS regression to evaluate the model.

Novel Methods

My methodological approach is distinct from previous post-conflict studies because it employs a novel, mixed-methods approach. Interview and survey data, demographic databases and epidemiologic data from the individual informant and the informant's context were collected.

I am employing an analysis that combines statistical analysis of population-level data. With increased stress in the post-conflict period, we hypothesize cancer rates will significantly rise in Kuwait, more so than if the war had not occurred.

Learning Areas:

Environmental health sciences
Public health or related research

Learning Objectives:
Describe the advantage of a life-course approach that contextualizes the Gulf War as an environmental justice issue

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I investigated this project as a two-time Fulbright Scholar to Kuwait. Also, my dissertation focused on this topic.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.